Current Pharmaceutical Design
Title:Meet the Editorial Board
Volume: 21 Issue: 17
Author(s): Gregory Y.H. Lip
Affiliation:
Export Options
About this article
Cite this article as:
Lip Y.H. Gregory, Meet the Editorial Board, Current Pharmaceutical Design 2015; 21 (17) . https://dx.doi.org/10.2174/138161282117150430124606
DOI https://dx.doi.org/10.2174/138161282117150430124606 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
24
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Exercise as a platform for pharmacotherapy development in cardiac diseases
Current Pharmaceutical Design Sprouty Proteins, A New Family of Receptor Tyrosine Kinase Inhibitors
Current Genomics Influence of Tumor Microenvironment on the Distribution and Elimination of Nano-formulations
Current Drug Metabolism Exosome-like Nanoparticles: A New Type of Nanocarrier
Current Medicinal Chemistry Visceral Adipose Tissue and Atherosclerosis
Current Vascular Pharmacology Phosphonamide-Based Metalloproteinase Inhibitors: A New Approach to the Development of Safer Metalloproteinase Inhibitors
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Noncardiac Surgery: Evaluating and Minimizing Cardiac Risk
Current Cardiology Reviews Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules
Current Medicinal Chemistry A Focus on Microfluidics and Nanotechnology Approaches for the Ultra Sensitive Detection of MicroRNA
MicroRNA Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Ubiquitin and ubiquitin-like proteins in cardiac disease and protection
Current Drug Targets Nanoparticles-Based Treatment for Bone Metastasis
Current Drug Targets Are Sex Differences in Outcomes of Patients with ACS from Observational Registries Similar to the Findings from Randomized Clinical Trials?
Current Pharmaceutical Design Signal Transduction in Human Cutaneous Melanoma and Target Drugs
Current Cancer Drug Targets Troponin in Newborns and Pediatric Patients
Cardiovascular & Hematological Agents in Medicinal Chemistry Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly
Current Pharmaceutical Design The Effects of Angiotensin II Signaling Blockade on Platelet Activity in Subjects with Hypertension
Current Hypertension Reviews Gender Differences in Non-Obstructive Coronary Artery Disease
Current Pharmaceutical Design Prevention and Treatment of Regimen-Related Mucosal Toxicity
Recent Patents on Anti-Cancer Drug Discovery Ghrelin in Hypothalamic Regulation of Energy Balance
Current Topics in Medicinal Chemistry